|
1
|
Biccard BM: Detection and management of
perioperative myocardial ischemia. Curr Opin Anaesthesiol.
27:336–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beattie WS and Wijeysundera DN:
Perioperative cardiac biomarkers: The utility and timing. Curr Opin
Crit Care. 19:334–341. 2013.PubMed/NCBI
|
|
3
|
Bousselmi R, Lebbi MA and Ferjani M:
Myocardial ischemic conditioning: Physiological aspects and
clinical applications in cardiac surgery. J Saudi Heart Assoc.
26:93–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salis S, Mazzanti VV, Merli G, Salvi L,
Tedesco CC, Veglia F and Sisillo E: Cardiopulmonary bypass duration
is an independent predictor of morbidity and mortality after
cardiac surgery. J Cardiothorac Vasc Anesth. 22:814–822. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ngaage DL, Cowen ME and Cale AR:
Cardiopulmonary bypass and left ventricular systolic dysfunction
impacts operative mortality differently in elderly and young
patients. Eur J Cardiothorac Surg. 35:235–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Salerno TA: Myocardial protection era:
From valve surgery to heart transplantation. Artif Organs.
36:939–942. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mentzer RM Jr: Myocardial protection in
heart surgery. J Cardiovasc Pharmacol Ther. 16:290–297. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma J, Li XH, Yan ZX, Liu AJ, Zhang WK and
Yang LN: Effect of myocardial protection during beating heart
surgery with right sub-axiliary approach. Chin Med J (Engl).
122:150–152. 2009.PubMed/NCBI
|
|
9
|
Ji B and Liu J: Myocardial protection
during heart surgery in China. Chin Med J (Engl). 120:62–67.
2007.PubMed/NCBI
|
|
10
|
De Hert S and Moerman A: Myocardial injury
and protection related to cardiopulmonary bypass. Best Pract Res
Clin Anaesthesiol. 29:137–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chambers DJ and Fallouh HB: Cardioplegia
and cardiac surgery: Pharmacological arrest and cardioprotection
during global ischemia and reperfusion. Pharmacol Ther. 127:41–52.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bolsin S, Colson M and Marsiglio A:
Perioperative β blockade. BMJ. 347:f56402013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McGory ML, Maggard MA and Ko CY: A
meta-analysis of perioperative beta blockade: What is the actual
risk reduction? Surgery. 138:171–179. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zaugg M, Lucchinetti E, Garcia C, Pasch T,
Spahn DR and Schaub MC: Anaesthetics and cardiac preconditioning.
Part II. Clinical implications. Br J Anaesth. 91:566–576. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ballester M, Llorens J,
Garcia-de-la-Asuncion J, Perez-Griera J, Tebar E, Martinez-Leon J,
Belda J and Juez M: Myocardial oxidative stress protection by
sevoflurane vs. propofol: A randomised controlled study in patients
undergoing off-pump coronary artery bypass graft surgery. Eur J
Anaesthesiol. 28:874–881. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Karuppasamy P, Chaubey S, Dew T, Musto R,
Sherwood R, Desai J, John L, Shah AM, Marber MS and Kunst G: Remote
intermittent ischemia before coronary artery bypass graft surgery:
A strategy to reduce injury and inflammation? Basic Res Cardiol.
106:511–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Steffens S, Montecucco F and Mach F: The
inflammatory response as a target to reduce myocardial ischaemia
and reperfusion injury. Thromb Haemost. 102:240–247.
2009.PubMed/NCBI
|
|
18
|
Gao Q, Hu J, Hu J, Yu Y, Ye H, Li Z and
Guan S: Calcium activated potassium channel and protein kinase C
participate in the cardiac protection of remote post conditioning.
Pak J Pharm Sci. 26:285–290. 2013.PubMed/NCBI
|
|
19
|
Kloner RA and Rezkalla SH: Cardiac
protection during acute myocardial infarction: Where do we stand in
2004? J Am Coll Cardiol. 44:276–286. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kloner RA and Rezkalla SH: Cardiac
protection during acute myocardial infarction: where do we stand in
2004? J Am Coll Cardiol. 44:276–286. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu A, Jiao X, Gao E, Li Y, Sharifi-Azad S,
Grunwald Z, Ma XL and Sun JZ: Tonic beta-adrenergic drive provokes
proinflammatory and proapoptotic changes in aging mouse heart.
Rejuvenation Res. 11:215–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ciçek D, Tamer L, Pekdemir H, Cin VG,
Yildirim H, Kara AA and Yurtdaş M: Coronary angioplasty induced
oxidative stress and its relation with metoprolol use and plasma
homocysteine levels. Anadolu Kardiyol Derg. 6:308–313.
2006.PubMed/NCBI
|
|
23
|
Iwai T, Tanonaka K, Kasahara S, Inoue R
and Takeo S: Protective effect of propranolol on mitochondrial
function in the ischaemic heart. Br J Pharmacol. 136:472–480. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lucas SK, Magee PG, Flaherty JT, Gott VL
and Gardner TJ: Additive myocardial protection during ischemic
arrest with propranolol and potassium cardioplegia. Surg Forum.
30:257–260. 1979.PubMed/NCBI
|
|
25
|
Ruff ME, Karayannacos PE, Baba N, Kakos
GS, Vasko JS, Williams TE and Kilman JW: Protective effect of
beta-adrenergic blockade and hypothermia on myocardial
ultrastructure. J Surg Res. 29:430–440. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miyazawa K, Fukuyama H, Komatsu E and
Yamaguchi I: Effects of propranolol on myocardial damage resulting
from coronary artery occlusion followed by reperfusion. Am Heart J.
111:519–524. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wiest D: Esmolol. A review of its
therapeutic efficacy and pharmacokinetic characteristics. Clin
Pharmacokinet. 28:190–202. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deng YK, Wei F, Li ZL, Zhang DG and Yang
SY: Esmolol protects the myocardium and facilitates direct version
intracardiac operation with a beating heart. Circ J. 66:715–717.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scorsin M, Mebazaa A, Al Attar N, Medini
B, Callebert J, Raffoul R, Ramadan R, Maillet JM, Ruffenach A,
Simoneau F, et al: Efficacy of esmolol as a myocardial protective
agent during continuous retrograde blood cardioplegia. J Thorac
Cardiovasc Surg. 125:1022–1029. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zangrillo A, Turi S, Crescenzi G, Oriani
A, Distaso F, Monaco F, Bignami E and Landoni G: Esmolol reduces
perioperative ischemia in cardiac surgery: A meta-analysis of
randomized controlled studies. J Cardiothorac Vasc Anesth.
23:625–632. 2009. View Article : Google Scholar : PubMed/NCBI
|
